I agree that this site is using cookies. You can find further informations here.
X
Phillips, Tycel J.
134  results:
Search for persons X
?
1

Taking a BiTE out of Lymphoma: Bispecific Antibodies in B-C..:

Weiss, Jonathan M. ; Phillips, Tycel J.
Cancers.  16 (2024)  9 - p. 1724 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Real‐world experience of axicabtagene ciloleucel, a CD19‐di..:

Othman, Tamer ; Baird, John H. ; Pak, Stacy...
British Journal of Haematology.  205 (2024)  1 - p. 368-372 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclona..:

Yuen, Sam ; Phillips, Tycel J. ; Bannerji, Rajat...
American Journal of Hematology.  99 (2024)  7 - p. 1281-1289 , 2024
Link: https://doi.org/10.1002/..
 
?
4

The PI3Kδ inhibitor zandelisib on intermittent dosing in re..:

Zelenetz, Andrew D. ; Jurczak, Wojciech ; Ribrag, Vincent...
HemaSphere.  8 (2024)  8 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Targeted therapies for follicular lymphoma:

, In: Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal,
Takiar, Radhika ; Phillips, Tycel J. - p. 123-145 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Improvements in Patient-Reported Outcomes in Relapsed or Re..:

Phillips, Tycel ; Lugtenburg, Pieternella ; Kalsekar, Anupama...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  3 - p. e78-e87.e2 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Acalabrutinib plus venetoclax and rituximab in treatment-na..:

Wang, Michael L ; Robak Prof., Tadeusz ; Maddocks, Kami J...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
8

Contributors:

, In: Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal,
Abdullahi, Hamisu ; Abubakar, Sharafudeen Dahiru ; Aliyu, Mansur... - p. xxi-xxiii , 2024
Link: https://doi.org/10.1016/..
 
?
9

A phase 2 study of the PI3Kδ inhibitor parsaclisib in relap..:

Phillips, Tycel J. ; Avigdor, Abraham ; Gurion, Ronit...
Blood Advances.  8 (2024)  4 - p. 867-877 , 2024
Link: https://doi.org/10.1182/..
 
?
10

TRES, a validated three-factor comorbidity score, is associ..:

Gordon, Max J. ; Bond, David A. ; Kittai, Adam S....
Haematologica.  108 (2023)  11 - p. 3110-3114 , 2023
Link: https://doi.org/10.3324/..
 
?
11

Retrospective Analysis With Propensity Score Matching of Pe..:

Burke, John M ; Liu, Nicholas ; Yu, Kristina S...
The Oncologist.  28 (2023)  6 - p. 520-530 , 2023
Link: https://doi.org/10.1093/..
 
?
12

EXABS-235-MCL CAR T-Cell Therapy and Bispecific Antibodies ..:

Kallam, Avyakta ; Danilov, Alexey ; Phillips, Tycel J.
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S124-S125 , 2023
Link: https://doi.org/10.1016/..
 
?
13

MCL-467 Glofitamab Monotherapy Induces High Complete Respon..:

Phillips, Tycel ; Dickinson, Michael ; Morschhauser, Franck...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S462 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and vene..:

Lasater, Elisabeth A. ; Amin, Dhara N. ; Bannerji, Rajat...
American Journal of Hematology.  98 (2023)  3 - p. 449-463 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Estimating long-term outcomes in classic Hodgkin lymphoma: ..:

Phillips, Tycel ; Migliaccio-Walle, Kristen ; Yu, Kristina S....
Leukemia & Lymphoma.  64 (2023)  5 - p. 1017-1025 , 2023
Link: https://doi.org/10.1080/..
 
1-15